针对瘤免疫治疗的免疫检查点的aptamers
Amir Mohammed Abker Abdu1, Yanfei Liu2, Rami Abduljabbar1
1Department of Pharmaceutics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.
Pharmaceutics
|August 28, 2025
概括
通过向PD-1/PD-L1和CTLA-4等免疫检查点, 提供一种新的癌症免疫治疗方法. 这些分子在克服治疗耐药性和增强抗瘤反应方面具有前景.
科学领域:
- 癌症学
- 免疫学
- 生物技术
背景情况:
- 瘤免疫疗法,特别是针对PD-1,PD-L1和CTLA-4的免疫检查点抑制剂,已经改变了癌症治疗.
- 目前ICI面临的挑战包括耐治疗性,与免疫相关的不良影响和高成本,需要新的治疗策略.
研究的目的:
- 提供针对癌症免疫治疗中的免疫检查点 (PD-1/PD-L1和CTLA-4) 的基于aptamer的策略的全面分析.
- 探索近期的aptamer设计和提高其治疗潜力的策略.
主要方法:
- 包括双特异性和多功能性aptamers在内的aptamer设计的最新进展.
- 讨论增强体稳定性,生物可用性和瘤透的策略 (化学修饰,纳米粒子结合).
- 分析了前临床和早期临床研究中阿普塔默在阻断免疫检查点和恢复T细胞活性方面的疗效.
主要成果:
- 对向分子具有很高的特异性和亲和力,可以作为基于抗体的替代疗法.
- 先进的aptamer设计 (双特异性,多功能) 显示出克服免疫抵抗的潜力.
- 化学修饰和纳米颗粒结合可以改善阿巴的药理动力学和瘤向性.
结论:
- 艾普塔默可以有效地阻断免疫检查点通路,恢复T细胞活性,并与其他免疫疗法协同进行优异的抗瘤反应.
- 基于Aptamer的癌症免疫疗法对开发更有效和个性化的治疗策略具有重大前景.
- 需要进行进一步的研究和临床研究,才能充分发挥阿普坦在癌症治疗中的潜力.
相关概念视频
01:27Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K